Similarly, when 20g or 40g of oral alanine were provided after insulin induced hypoglycemia was achieved via a bolus subcutaneous injection, individuals with T1D displayed a reduced glucagon response relative to healthy controls but still had a significant and dose-dependent increase in both peak plasma glucagon and glucose (31). The gene discussed is INS; the disease is Hypoglycemia.